[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2021-2025 Germany Therapeutic Drug Monitoring (TDM) Market for 28 Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

October 2021 | 249 pages | ID: 2E2D967E978AEN
Venture Planning Group

US$ 2,450.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new 249-page report from LeadingMarketResearch.com provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

The report is available by section, and can be customized to specific information needs and budget.

The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.

During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This report is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.

Contains 249 pages and 19 tables
INTRODUCTION

MARKET AND TECHNOLOGY OVERVIEW

A. Major Therapeutic Drug Monitoring Tests
  1. Overview
  2. Amikacin
  3. Apixaban
  4. Argatroban
  5. Betrixaban
  6. Carbamazepine
  7. Cyclosporin
  8. Dabigatran
  9. Digoxin
  10. Edoxaban
  11. Everolimus
  12. Fluindione
  13. Gentamicin
  14. Levetiracetam
  15. Lithium
  16. Methotrexate
  17. NAPA/Procainamide
  18. Phenobarbital
  19. Phenytoin
  20. Quinidine
  21. Rivaroxaban
  22. Sirolimus
  23. Tacrolimus
  24. Theophylline
  25. Tobramycin
  26. Topirimate
  27. Valproic Acid
  28. Vancomycin
  29. Warfarin
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alere/Inverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies and Their Potential Applications
  1. Monoclonal and Polyclonal Antibodies
  2. Immunoassays
    a. Technological Principle
    d. Chemiluminescence
    c. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      EMIT
      Electrochemical
    d. Radioimmunoassays (RIA)
    e. Immunoprecipitation
    f. Affinity Chromatography
  3. Tandem Mass Spec
  4. IT and Automation
  5. Dry Chemistry
  6. Biosensors
D. Market Size, Growth and Major Supplier Shares

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
IL/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako

LIST OF TABLES

Major Companies Developing or Marketing TDM Tests
Major Companies Developing or Marketing Digoxin Tests
Major Companies Developing or Marketing Lithium Tests
Major Companies Developing or Marketing Phenytoin Tests
Major Companies Developing or Marketing Theophylline Tests
Major Companies Developing or Marketing Valproic Tests
Major Companies Developing or Marketing Biosensors for Genetic Disease Testing
Germany, Laboratories Performing TDM Tests By Market Segment
Germany, Hospital Laboratories Performing TDM Tests By Bed Size
Germany, Commercial/Private Laboratories Performing TDM Tests By Annual Test Volume
Germany, TDM Test Volume Forecast By Market Segment
Germany, Hospital Laboratories, TDM Test Volume Forecast by Assay
Germany, Commercial/Private Laboratories, TDM Test Volume Forecast by Assay
Germany, Physician Offices/Group Practices, TDM Test Volume Forecast by Assay
Germany, TDM Reagent Market Forecast by Market Segment
Germany, Hospital Laboratories, TDM Reagent Market Forecast by Assay
Germany, Commercial/Private Laboratories, TDM Reagent Market Forecast by Assay
Germany, Physician Offices/Group Practices, TDM Reagent Market Forecast by Assay
Germany, Major Suppliers of Immunodiagnostic Products, Estimated Market Shares


More Publications